Unmet Needs in Pharmacological Treatment of Apathy in Alzheimer’s Disease: A Systematic Review
Background: Apathy is one of the most prevalent neuropsychiatric symptoms encountered in Alzheimer’s disease (AD) and may be an early sign in the development of dementia persisting over the disease course. It has been associated with poor disease outcome, impaired daily functioning, and significant...
Main Authors: | Christos G. Theleritis, Kostas T. Siarkos, Antonios M. Politis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01108/full |
Similar Items
-
A Systematic Review of Pharmacological Interventions for Apathy in Aging Neurocognitive Disorders
by: Christos Theleritis, et al.
Published: (2023-07-01) -
Use of methylphenidate in alzheimer’s dementia: Effect on apathy
by: R. Borralho, et al.
Published: (2021-04-01) -
Pharmacologic Approaches for the Management of Apathy in Neurodegenerative Disorders
by: Anamaria Bogdan, et al.
Published: (2020-01-01) -
An Update on Apathy in Alzheimer’s Disease
by: Helena Dolphin, et al.
Published: (2023-07-01) -
Brazilian caregiver version of the Apathy Scale
by: Henrique Cerqueira Guimarães, et al.